The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia
- PMID: 17707831
- DOI: 10.1016/j.beha.2007.02.003
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia
Abstract
New findings support the view that chronic lymphocytic leukemia (CLL) is a genetic disease in which the main alterations occur in a new class of genes named microRNAs (miRNAs). Cases with good prognostic features typically are characterized by miRNA down-regulation of genes miR-15a and miR-16-1, located at 13q14.3. Both microRNAs negatively regulate BCL2 at a post-transcriptional level. On the other hand, in CLL cases that use unmutated immunoglobulin heavy-chain variable-region genes (IgV(H)) or have high-level expression of the 70-kD zeta-associated protein (ZAP-70) have high levels of TCL1 due to low-level expression of miR-29 and miR-181, which directly target this oncogene. Conceivably, these miRNAs might be used to target BCL2 or TCL1 for therapy of this disease.
Similar articles
-
Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.Semin Oncol. 2006 Apr;33(2):167-73. doi: 10.1053/j.seminoncol.2006.01.010. Semin Oncol. 2006. PMID: 16616063 Review.
-
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.Cancer Res. 2006 Dec 15;66(24):11590-3. doi: 10.1158/0008-5472.CAN-06-3613. Cancer Res. 2006. PMID: 17178851
-
New insights into the pathogenesis of chronic lymphocytic leukemia.Semin Cancer Biol. 2010 Dec;20(6):377-83. doi: 10.1016/j.semcancer.2010.10.012. Epub 2010 Oct 26. Semin Cancer Biol. 2010. PMID: 21029776 Review.
-
MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.Cancer Genet Cytogenet. 2010 Dec;203(2):127-33. doi: 10.1016/j.cancergencyto.2010.09.007. Cancer Genet Cytogenet. 2010. PMID: 21156224 Review.
-
MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.Br J Haematol. 2007 Dec;139(5):709-16. doi: 10.1111/j.1365-2141.2007.06868.x. Br J Haematol. 2007. PMID: 18021085 Review.
Cited by
-
Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.Tumour Biol. 2012 Dec;33(6):1933-42. doi: 10.1007/s13277-012-0454-8. Epub 2012 Jul 19. Tumour Biol. 2012. PMID: 22811001
-
miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML).PLoS One. 2012;7(3):e32834. doi: 10.1371/journal.pone.0032834. Epub 2012 Mar 19. PLoS One. 2012. PMID: 22442671 Free PMC article.
-
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.Oncotarget. 2015 Aug 14;6(23):19807-18. doi: 10.18632/oncotarget.4415. Oncotarget. 2015. PMID: 26090867 Free PMC article.
-
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.Blood. 2010 Apr 8;115(14):2852-63. doi: 10.1182/blood-2009-10-230060. Epub 2010 Feb 12. Blood. 2010. PMID: 20154216 Free PMC article.
-
Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.Clin Transl Med. 2016 Mar;5(1):13. doi: 10.1186/s40169-016-0093-6. Epub 2016 Apr 6. Clin Transl Med. 2016. PMID: 27053248 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials